Colon Cancer Market Size , Share , Analysis , Forecast , Industry Strategy , Opportunity , Trends , Insights , Growth , Price , Research Survey , Segment , Outlook and Challenges Report To 2016
Colon Cancer Market Size , Share , Analysis , Forecast , Industry Strategy , Opportunity , Trends , Insights , Growth , Price , Research Survey , Segment , Outlook and Challenges Report To 2016
Market Reports Center latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer Pipeline Review , H2 2016 , provides an overview of the Colon Cancer ( Oncology ) pipeline landscape .
Colon cancer is cancer that starts in the large intestine ( colon ). There is no single cause of colon cancer . Nearly all colon cancers begin as noncancerous ( benign ) polyps , which slowly develop into cancer . Many cases of colon cancer have no symptoms . The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen , blood in the stool , diarrhea , constipation , or other change in bowel habits , narrow stools and weight loss with no known reason . Treatment includes surgery , radiation therapy and chemotherapy .
Report Highlights
Market Reports Center Pharmaceutical and Healthcare latest pipeline guide Colon Cancer – Pipeline Review , H2 2016 , provides comprehensive information on the therapeutics under development for Colon Cancer ( Oncology ), complete with analysis by stage of development , drug target , mechanism of action ( MoA ), route of administration ( RoA ) and molecule type . The guide covers the descriptive pharmacological action of the therapeutics , its complete research and development history and latest news and press releases .
To know more about this report , Click here : https :// marketreportscenter . com / reports / 490762 / colon-cancer-pipeline-review-h2-2016
The Colon Cancer ( Oncology ) pipeline guide also reviews of key players involved in therapeutic development for Colon Cancer and features dormant and discontinued projects . The guide covers therapeutics under Development by Companies / Universities / Institutes , the molecules developed by Companies in Phase III , Phase II , Phase I , IND / CTA Filed , Preclinical and Discovery stages are 1 , 6 , 35 , 3 , 155 and 14 respectively . Similarly , the Universities portfolio in Phase II , Phase I , Preclinical and Discovery stages comprises 2 , 2 , 46 and 16 molecules , respectively .
Colon Cancer ( Oncology ) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios , enhances decision making capabilities and helps to create